EFFECTIVENESS OF A CLINICAL DECISION SUPPORT SYSTEM INCORPORATING A VALIDATED QT INTERVAL PROLONGATION RISK SCORE FOR REDUCING THE RISK OF QT INTERVAL PROLONGATION IN HOSPITALIZED PATIENTS

被引：1
|
作者：
Tisdale, James
Wroblewski, Heather
Kingery, Joanna
Overholser, Brian
Trujillo, Tate N.
Kovacs, Richard
机构：
[1] Purdue Univ, Indianapolis, IN USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 59卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(12)61800-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1799 / E1799
页数：1
相关论文
共 50 条
  • [41] Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice
    Isbister, Geoffrey K.
    Page, Colin B.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (01) : 48 - 57
  • [42] The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: Comparison with QT interval prolongation for assessment of risk of Torsades de Pointes
    Tisdale, JE
    Rasty, S
    Padhi, ID
    Sharma, ND
    Rosman, H
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (12): : 1310 - 1318
  • [43] Cholinesterase inhibitors: risk of QT-interval prolongation, torsade de pointes
    [J]. Reactions Weekly, 2022, 1917 (1) : 3 - 3
  • [44] Drug-Induced QT Interval Prolongation: Mechanisms, Risk Factors, Genetics and Clinical Management
    Akturk, Gozde
    Kalkan, Sule
    [J]. JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2019, 3 (03): : 193 - 198
  • [45] A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?
    Hancox, Jules C.
    [J]. EXPERIMENTAL PHYSIOLOGY, 2017, 102 (11) : 1395 - 1396
  • [46] Relationship between a risk score for QT interval prolongation and mortality across rural and urban inpatient facilities
    Tan, Malinda S.
    Heise, C. William
    Gallo, Tyler
    Tisdale, James E.
    Woosley, Raymond L.
    Antonescu, Corneliu C.
    Gephart, Sheila M.
    Malone, Daniel C.
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2023, 77 : 4 - 9
  • [47] High Prevalence of QT Interval Prolongation in Hospitalized Patients is Linked to Mortality: Results of the QT in Practice (QTIP) Study
    Pickham, David
    Shinn, Julie
    Funk, Marjorie
    Drew, Barbara J.
    [J]. CIRCULATION, 2010, 122 (21)
  • [48] Citalopram, escitalopram, risk of dose-dependent QT-interval prolongation
    [J]. Reactions Weekly, 2022, 1916 (1) : 2 - 2
  • [49] Ever-expanding clinical implications of QT interval prolongation
    Ramakrishna, Harish
    O'Hare, Meabh
    Mookadam, Farouk
    [J]. FUTURE CARDIOLOGY, 2015, 11 (02) : 133 - 135
  • [50] Risk factors for QT interval prolongation: Data from 350 patients hospitalised in a psychiatric unit
    Pinoit, JM
    Trojak, B
    Andre, D
    Bonin, B
    Gisselmann, A
    [J]. EUROPEAN PSYCHIATRY, 2004, 19 : 230S - 230S
12345